We're dedicated to providing safe and effective medicines, alongside services and support for healthy outcomes. This involves superior science, creativity, and collaboration with stakeholders at all levels. As a leading pharma company in the U.S., we focus on devastating diseases and complex medical challenges across six specific therapeutic areas: Cardiovascular & Metabolism, Immunology, Infectious Diseases & Vaccines, Neuroscience, Oncology, and Pulmonary Hypertension.
Janssen aims to fund programs and initiatives that improve patient access to treatment and services, advance health equity, and strengthen frontline health workforces within specific therapeutic areas. The grant supports disease awareness, patient empowerment and advocacy, and care linkage efforts, prioritizing health system improvements with measurable outcomes. In Pulmonary Arterial Hypertension, it seeks to fund early diagnosis, disease intervention, awareness, caregiver support, patient empowerment, skills improvement for healthcare professionals and caregivers, healthcare disparity addressing efforts, and advocacy on access to care.